US FDA confirms reinvestigation of alleged misconduct by agency staff
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has confirmed that the Office of Inspector General at the Department of Health and Human Services is re-opening a controversial investigation into the alleged misconduct of senior managers at the agency's Center for Devices and Radiological Health1.